Isolated tricuspid regurgitation: Outcomes and therapeutic interventions

Heart

Volumn 104, Issue 10, 2018, Pages 798-806

  Fender, Erin A ^a   Zack, Chad J ^a,b   Nishimura, Rick A ^a  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

transcatheter valve interventions; tricuspid valve disease; valve disease surgery

Indexed keywords

DIURETIC AGENT;

ARTICLE; CARDIOVASCULAR MORTALITY; CONSTRICTIVE PERICARDITIS; DETERIORATION; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; FORWARD HEART FAILURE; HEART CATHETERIZATION; HEART DILATATION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HEART VENTRICLE SIZE; HUMAN; ISOLATED HEART; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSATILITY INDEX; RESTRICTIVE CARDIOMYOPATHY; SINUS RHYTHM; SURGICAL RISK; TRICUSPID VALVE REGURGITATION; TWO-DIMENSIONAL IMAGING; VENOUS PRESSURE; HEART VALVE REPLACEMENT; PATIENT CARE; PROCEDURES; RISK ASSESSMENT; TREATMENT OUTCOME;

HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT CARE MANAGEMENT; RISK ADJUSTMENT; TREATMENT OUTCOME; TRICUSPID VALVE INSUFFICIENCY;

EID: 85045471570     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2017-311586     Document Type: Article

References (49)

1. Vassileva CM, Shabosky J, Boley T, et al. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg 2012; 143: 1043-9.
2. Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 2006; 132: 1258-61.
3. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83: 897-902.
4. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43: 405-9.
5. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 2014; 7: 1185-94.
6. Paniagua D, Aldrich HR, Lieberman EH, et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol 1998; 82: 1130-2.
7. Chang JD, Manning WJ, Ebrille E, et al. TRicuspid valve dysfunction following pacemaker or cardioverter-defibrillator Implantation. J Am Coll Cardiol 2017; 69: 2331-41.
8. Mutlak D, Lessick J, Reisner SA, et al. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr 2007; 20: 405-8.
9. Höke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 2014; 100: 960-8.
10. Utsunomiya H, Itabashi Y, Mihara H, et al. Functional tricuspid regurgitation caused by chronic atrial fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging 2017; 10.
11. Andersen MJ, Nishimura RA, Borlaug BA. The hemodynamic basis of exercise intolerance in tricuspid regurgitation. Circ Heart Fail 2014; 7: 911-7.
12. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002; 90: 1405-9.
13. Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 2008; 14: 824-30.
14. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307-32.
15. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
16. Mediratta A, Addetia K, Yamat M, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging 2014; 7: 337-47.
17. Nishimura K, Okayama H, Inoue K, et al. Visualization of traumatic tricuspid insufficiency by three-dimensional echocardiography. J Cardiol 2010; 55: 143-6.
18. Hung J, Koelling T, Semigran MJ, et al. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 1998; 82: 1301-3.
19. Messika-Zeitoun D, Thomson H, Bellamy M, et al. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. J Thorac Cardiovasc Surg 2004; 128: 296-302.
20. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:e57-185.
21. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-96.
22. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004; 127: 674-85.
23. Hwang HY, Kim KH, Kim KB, et al. Treatment for severe functional tricuspid regurgitation: annuloplasty versus valve replacement. Eur J Cardiothorac Surg 2014; 46:e21-27.
24. Moraca RJ, Moon MR, Lawton JS, et al. Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg 2009; 87: 83-9.
25. Shinn SH, Schaff HV. Evidence-based surgical management of acquired tricuspid valve disease. Nat Rev Cardiol 2013; 10: 190-203.
26. Marquis-Gravel G, Bouchard D, Perrault LP, et al. Retrospective cohort analysis of 926 tricuspid valve surgeries: clinical and hemodynamic outcomes with propensity score analysis. Am Heart J 2012; 163: 851-8.
27. Rivera R, Duran E, Ajuria M. Carpentier's flexible ring versus De Vega's annuloplasty. A prospective randomized study. J Thorac Cardiovasc Surg 1985; 89: 196-203.
28. Hwang HY, Kim KH, Kim KB, et al. Reoperations after tricuspid valve repair: re-repair versus replacement. J Thorac Dis 2016; 8: 133-9.
29. Fukuda S, Song JM, Gillinov AM, et al. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 2005; 111: 975-9.
30. Ghanta RK, Chen R, Narayanasamy N, et al. Suture bicuspidization of the tricuspid valve versus ring annuloplasty for repair of functional tricuspid regurgitation: midterm results of 237 consecutive patients. J Thorac Cardiovasc Surg 2007; 133: 117-26.
31. Mangoni AA, DiSalvo TG, Vlahakes GJ, et al. Outcome following isolated tricuspid valve replacement. Eur J Cardiothorac Surg 2001; 19: 68-73.
32. Ohata T, Kigawa I, Tohda E, et al. Comparison of durability of bioprostheses in tricuspid and mitral positions. Ann Thorac Surg 2001; 71:S240-243.
33. Nakano K, Ishibashi-Ueda H, Kobayashi J, et al. Tricuspid valve replacement with bioprostheses: long-term results and causes of valve dysfunction. Ann Thorac Surg 2001; 71: 105-9.
34. Van Nooten GJ, Caes F, Taeymans Y, et al. Tricuspid valve replacement: postoperative and long-term results. J Thorac Cardiovasc Surg 1995; 110: 672-9.
35. Cho WC, Park CB, Kim JB, et al. Mechanical valve replacement versus bioprosthetic valve replacement in the tricuspid valve position. J Card Surg 2013; 28: 212-7.
36. Liu P, Qiao WH, Sun FQ, et al. Should a mechanical or biological prosthesis be used for a tricuspid valve replacement? A meta-analysis. J Card Surg 2016; 31: 294-302.
37. Rizzoli G, Vendramin I, Nesseris G, et al. Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg 2004; 77: 1607-14.
38. Topilsky Y, Khanna AD, Oh JK, et al. Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 2011; 123: 1929-39.
39. Kim JB, Jung SH, Choo SJ, et al. Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation. J Thorac Cardiovasc Surg 2013; 146: 278-84.
40. Kim YJ, Kwon DA, Kim HK, et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation 2009; 120: 1672-8.
41. Lee JW, Song JM, Park JP, et al. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 2010; 74: 375-80.
42. Pfannmüller B, Misfeld M, Borger MA, et al. Isolated reoperative minimally invasive tricuspid valve operations. Ann Thorac Surg 2012; 94: 2005-10.
43. Ratnatunga CP, Edwards MB, Dore CJ, et al. Tricuspid valve replacement: UK Heart valve registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg 1998; 66: 1940-7.
44. Staab ME, Nishimura RA, Dearani JA. Isolated tricuspid valve surgery for severe tricuspid regurgitation following prior left heart valve surgery: analysis of outcome in 34 patients. J Heart Valve Dis 1999; 8: 567-74.
45. Attenhofer Jost CH, Connolly HM, Scott CG, et al. Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement. J Am Coll Cardiol 2012; 59: 2101-6.
46. Kwon DA, Park JS, Chang HJ, et al. Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity. Am J Cardiol 2006; 98: 659-61.
47. Kuwaki K, Morishita K, Tsukamoto M, et al. Tricuspid valve surgery for functional tricuspid valve regurgitation associated with left-sided valvular disease. Eur J Cardiothorac Surg 2001; 20: 577-82.
48. Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter therapies for treating Tricuspid regurgitation. J Am Coll Cardiol 2016; 67: 1829-45.
49. McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Transcatheter tricuspid valve-invalve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation 2016; 133: 1582-93.